Developing story — details emerging. Check the source link for the latest updates.
Source: [Seeking Alpha](https://seekingalpha.com/article/4918850-replimune-stock-buoyant-on-third-try-at-rp1-approval-fda-adcom-may-be-crucial?source=feed_all_articles)